Back
Cousins Properties 10K Form
Sell
40
CUZ
Cousins Properties
Last Price:
29.99
Seasonality Move:
5.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | CUZ/Cousins Properties Quarterly |
2023-10-26 | 10Q | CUZ/Cousins Properties Quarterly |
2023-07-27 | 10Q | CUZ/Cousins Properties Quarterly |
2023-04-27 | 10Q | CUZ/Cousins Properties Quarterly |
2022-10-27 | 10Q | CUZ/Cousins Properties Quarterly |
2022-07-28 | 10Q | CUZ/Cousins Properties Quarterly |
Receive CUZ News And Ratings
See the #1 stock for the next 7 days that we like better than CUZ
CUZ Financial Statistics
Sales & Book Value
Annual Sales: | $802.87M |
---|---|
Cash Flow: | $117.39M |
Price / Cash Flow: | 12.9 |
Annual Sales: | $29.03 |
Price / Book: | 1.06 |
Profitability
EPS (TTM): | 0.33000 |
---|---|
Net Income (TTM): | $51.11M |
Gross Margin: | $536.44M |
Return on Equity: | 1.13% |
Return on Assets: | 0.67% |
Cousins Properties Earnings Forecast
Key Cousins Properties Financial Ratios
- The Gross Profit Margin over the past 17 years for CUZ is 66.81%.
- The Selling, General & Administrative Expenses for CUZ have been equal to 4.03% of Gross Profit Margin.
- The Interest Expense is 127.12% of Operating Income.
- The Net Earning history of CUZ is 10.33% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 20 years.
Cousins Properties Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Office REITs |
Sector: | Real Estate |
Current Symbol: | CUZ |
CUSIP: | 222795 |
Website: | cousins.com |
Debt
Debt-to-Equity Ratio: | 0.6 |
---|---|
Current Ratio: | 0.56 |
Quick Ratio: | 0.56 |
Price-to-Earnings
Trailing P/E Ratio: | 55.69 |
---|---|
Forward P/E Ratio: | 117.81 |
CUZ Technical Analysis vs Fundamental Analysis
Sell
40
Cousins Properties (CUZ)
is a Sell
Is Cousins Properties a Buy or a Sell?
-
Cousins Properties stock is rated a Sell
The current Cousins Properties [CUZ] share price is $30.63. The Score for CUZ is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.